Pulmonx (LUNG) Cash from Operations (2019 - 2025)
Pulmonx (LUNG) reported Cash from Operations of 8192000.0 for Q3 2025, down 13.78% year-over-year from 9501030.93 in Q3 2024, and down 110.05% on a QoQ basis from 3900000.0 in Q2 2025.
Pulmonx (LUNG) has 7 years of Cash from Operations data on file, last reported at 8192000.0 in Q3 2025.
- Quarterly Cash from Operations fell 13.78% year-over-year to 8192000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 32029000.0 (up 3.53% YoY) and the FY2024 annual result came in at 31537000.0, up 16.12% from the prior year.
- Cash from Operations declined to 8192000.0 in Q3 2025 per LUNG's latest filing, from 3900000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 3900000.0 in Q2 2025 and bottomed at 15026000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 9564000.0 (2022), against an average of 9521684.21.
- The widest annual swing landed in 2021, when Cash from Operations slumped 64.94%; it then soared 32.82% in 2025.
- Tracing LUNG's Cash from Operations over 5 years: stood at 10700000.0 in 2021, then climbed by 8.36% to 9806000.0 in 2022, then advanced by 14.34% to 8400000.0 in 2023, then advanced by 19.8% to 6737000.0 in 2024, then slipped by 21.6% to 8192000.0 in 2025.
- Per Business Quant, the three latest LUNG Cash from Operations figures stand at 8192000.0 (Q3 2025), 3900000.0 (Q2 2025), and 13200000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.74 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 220.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 525.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 335.40 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.19 Mn |
| Sep 30, 2025 | -8.19 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Jun 30, 2025 | -3.90 Mn |
| Mar 31, 2025 | -13.20 Mn |
| Mar 31, 2025 | -13.20 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Dec 31, 2024 | -6.74 Mn |
| Sep 30, 2024 | -7.20 Mn |
| Sep 30, 2024 | -7.20 Mn |
| Jun 30, 2024 | -5.81 Mn |
| Jun 30, 2024 | -5.81 Mn |
| Mar 31, 2024 | -11.80 Mn |
| Mar 31, 2024 | -11.80 Mn |
| Dec 31, 2023 | -8.40 Mn |
| Dec 31, 2023 | -8.40 Mn |
| Sep 30, 2023 | -8.70 Mn |
| Sep 30, 2023 | -8.70 Mn |
| Jun 30, 2023 | -7.90 Mn |
| Jun 30, 2023 | -7.90 Mn |
| Mar 31, 2023 | -12.60 Mn |
| Mar 31, 2023 | -12.60 Mn |
| Dec 31, 2022 | -9.81 Mn |
| Dec 31, 2022 | -9.81 Mn |
| Sep 30, 2022 | -10.69 Mn |
| Sep 30, 2022 | -10.69 Mn |
| Jun 30, 2022 | -9.56 Mn |
| Jun 30, 2022 | -9.56 Mn |
| Mar 31, 2022 | -15.03 Mn |
| Mar 31, 2022 | -15.03 Mn |
| Dec 31, 2021 | -10.70 Mn |
| Dec 31, 2021 | -10.70 Mn |
| Sep 30, 2021 | -8.30 Mn |
| Sep 30, 2021 | -8.30 Mn |
| Jun 30, 2021 | -12.70 Mn |
| Jun 30, 2021 | -12.70 Mn |
| Mar 31, 2021 | -9.70 Mn |
| Mar 31, 2021 | -9.70 Mn |
| Dec 31, 2020 | -7.26 Mn |
| Dec 31, 2020 | -7.26 Mn |
| Sep 30, 2020 | -5.87 Mn |
| Sep 30, 2020 | -5.87 Mn |
| Jun 30, 2020 | -7.70 Mn |
| Jun 30, 2020 | -7.70 Mn |
| Mar 31, 2020 | -9.80 Mn |
| Mar 31, 2020 | -9.80 Mn |
| Dec 31, 2019 | -3.47 Mn |
| Dec 31, 2019 | -3.47 Mn |